Marker Therapeutics Inc. (MRKR)
NASDAQ: MRKR
· Real-Time Price · USD
1.18
-0.10 (-7.81%)
At close: May 09, 2025, 12:47 PM
Marker Therapeutics Revenue
Marker Therapeutics reported an annual revenue of $6.59M, reflecting a 99.06% growth. For the quarter ending December 31, 2024, Marker Therapeutics generated $2.25M in revenue.
Revenue (ttm)
$6.59M
Revenue Growth
99.06%
Price / Sales Ratio
4.24
Revenue / Employee
$1.32M
Employees
5
Market Cap
13.29M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|